0001209191-21-025726.txt : 20210406
0001209191-21-025726.hdr.sgml : 20210406
20210406175459
ACCESSION NUMBER: 0001209191-21-025726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210405
FILED AS OF DATE: 20210406
DATE AS OF CHANGE: 20210406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRYCE RICHARD PAUL
CENTRAL INDEX KEY: 0001553037
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35703
FILM NUMBER: 21810151
MAIL ADDRESS:
STREET 1: C/O PUMA BIOTECHNOLOGY, INC.
STREET 2: 10880 WILSHIRE BOULEVARD, SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PUMA BIOTECHNOLOGY, INC.
CENTRAL INDEX KEY: 0001401667
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770683487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
BUSINESS PHONE: (424) 248-6500
MAIL ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATIVE ACQUISITIONS CORP
DATE OF NAME CHANGE: 20070601
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-05
0
0001401667
PUMA BIOTECHNOLOGY, INC.
PBYI
0001553037
BRYCE RICHARD PAUL
C/O PUMA BIOTECHNOLOGY, INC.
10880 WILSHIRE BLVD., SUITE 2150
LOS ANGELES
CA
90024
0
1
0
0
SEE REMARKS
COMMON STOCK
2021-04-05
4
S
0
426
9.8029
D
121662
D
The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
Title of Reporting Person: Chief Medical and Scientific Officer
/s/ Richard Paul Bryce
2021-04-06